Literature DB >> 20057984

[Testosterone and erectile dysfunction].

T Diemer1.   

Abstract

Primary hypogonadism represents a classic but rare cause of erectile dysfunction (ED) in men. Therapy with testosterone as monotherapy is therefore unlikely to cure ED in the typical ED patient. However, recent developments indicate a much greater role of testosterone in erectile function than has been supposed in the past. Serum testosterone levels decline in men with increasing age. Aging men might develop late-onset hypogonadism (LOH) associated with characteristic symptoms. Typical symptoms of LOH are represented by decreased libido and sexual function, osteoporosis, altered distribution of body fat, overall reduction in physical strength, and alterations in the general mood. Experimental and clinical studies over the last few years have also pointed out that hypogonadism results in characteristic alterations of the erectile tissue of the penis. These alterations might be reversible in response to hormone therapy with testosterone. Particularly testosterone might be a helpful supportive therapy in cases where PDE-5 antagonists have tended to lose their effectiveness on the erectile tissue in the treatment of ED.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057984     DOI: 10.1007/s00120-009-2202-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

Review 1.  Sexuality of the elderly.

Authors:  W Weidner; J Altwein; E Hauck; M Beutel; E Brähler
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

2.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations.

Authors:  E Nieschlag; R Swerdloff; H M Behre; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; J E Morley; C Schulman; C Wang; W Weidner; F C W Wu
Journal:  Int J Androl       Date:  2005-06

Review 3.  ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Int J Impot Res       Date:  2008-10-16       Impact factor: 2.896

4.  Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: a series of case reports.

Authors:  Aksam A Yassin; Farid Saad; Abdulmaged Traish
Journal:  J Sex Med       Date:  2006-07       Impact factor: 3.802

5.  Correlations between hormones, physical, and affective parameters in aging urologic outpatients.

Authors:  M E Beutel; J Wiltink; E W Hauck; D Auch; H M Behre; E Brähler; W Weidner
Journal:  Eur Urol       Date:  2005-03-09       Impact factor: 20.096

Review 6.  Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

Authors:  Abdulmaged M Traish; Irwin Goldstein; Noel N Kim
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

7.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study.

Authors:  Henry A Feldman; Christopher Longcope; Carol A Derby; Catherine B Johannes; Andre B Araujo; Andrea D Coviello; William J Bremner; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome.

Authors:  Farid Saad; Louis Gooren; Ahmad Haider; Aksam Yassin
Journal:  Arch Androl       Date:  2007 Nov-Dec

Review 9.  Androgen replacement therapy and prostate safety.

Authors:  Alvaro Morales
Journal:  Eur Urol       Date:  2002-02       Impact factor: 20.096

Review 10.  Testosterone and erectile dysfunction.

Authors:  Aksam A Yassin; Farid Saad
Journal:  J Androl       Date:  2008-07-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.